Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Specific Effects of Escitalopram on Neuroendocrine Response

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00150527
Recruitment Status : Completed
First Posted : September 8, 2005
Last Update Posted : February 5, 2009
Sponsor:
Collaborator:
H. Lundbeck A/S
Information provided by:
Queen's University

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : December 2006
Actual Study Completion Date : December 2007
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 21, 2015
November 25, 2015
2 January 21, 2016
February 17, 2016
3 December 1, 2016
January 27, 2017